Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life

Optimal therapy of patients with steroid-resistant primary focal segmental glomerulosclerosis (FSGS) remains controversial. This report describes the initial study design, baseline characteristics, and quality of life of patients enrolled in the FSGS Clinical Trial, a large multicenter randomized st...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gipson, Debbie S., Trachtman, Howard, Kaskel, Frederick J., Radeva, Milena K., Gassman, Jennifer, Greene, Tom H., Moxey-Mims, Marva M., Hogg, Ronald J., Watkins, Sandra L., Fine, Richard N., Middleton, John P., Vehaskari, V. M., Hogan, Susan L., Vento, Suzzane, Flynn, Patti A., Powell, Leslie M., McMahan, June L., Siegel, Norman, Friedman, Aaron L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3306823/
https://ncbi.nlm.nih.gov/pubmed/21178977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2010.485
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky